FC
ADVM

FORA Capital’s Adverum Biotechnologies ADVM Stock Holding History

FORA Capital’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-420
Closed -$88K – 624
2020
Q2 		$88K Buy
+420
New +$74.4K 0.03% 523

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

FORA Capital's ADVM Position: Q3 2020 in Review

FORA Capital sold out of Adverum Biotechnologies (ADVM) in Q3 2020, closing a stake of 420 shares — an estimated $88K sold.

FORA Capital first reported a position in ADVM in Q2 2020 and held it in 1 quarter. The position peaked at $88K in Q2 2020. 160 funds tracked by Wall St. Rank hold ADVM as of Q3 2020.

  • FORA Capital reported no remaining Adverum Biotechnologies position as of Q3 2020 after selling out during the quarter.
  • FORA Capital sold 420 Adverum Biotechnologies shares in Q3 2020, an estimated $88K.
  • FORA Capital first reported a position in Adverum Biotechnologies in Q2 2020 and held it in 1 quarter.
  • FORA Capital's Adverum Biotechnologies position peaked at $88K in Q2 2020.
  • 160 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2020.

Based on FORA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.